Summary
49 / 100 · Bulios Score
What speaks for it
- It has no debt and holds $109.5M in cash.
What to watch
- The share price is above the Bulios Fair Price.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 8 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Is it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $45.1M.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Manufacturing Revenue 100%
By region
The company reports no revenue by region.
Manufacturing Revenue brings in 100% of revenue.
Segments in detail